Word

MYMRD

Status

Dead

Status Code

602

Status Date

Friday, October 16, 2015

Serial Number

86543080

Mark Type

4000

Filing Date

Monday, February 23, 2015

Abandoned Date

Friday, September 18, 2015

Trademark Owner History

Invivoscribe Technologies, Inc.

Classifications

1 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for nonmedical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use

5 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids

42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

Trademark Events

Oct 16, 2015

Abandonment Notice Mailed - Failure To Respond

Oct 16, 2015

Abandonment - Failure To Respond Or Late Response

Mar 17, 2015

Notification Of Priority Action E-Mailed

Mar 17, 2015

Priority Action E-Mailed

Mar 17, 2015

Priority Action Written

Mar 11, 2015

Assigned To Examiner

Mar 9, 2015

New Application Office Supplied Data Entered In Tram

Feb 26, 2015

New Application Entered In Tram